Tuberculosis Testing and Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Test Type (Radiographic Method, Cytokine Detection Assay, Nucleic Acid Testing, Detection of Latent Infection, Diagnostic Laboratory Method, Detection of Drug Resistance, and Others); End Use (Clinics, Hospitals, Research Institutes and Academics, Reference Laboratories, and Others), and Geography

Report Code: TIPRE00022313 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Tuberculosis (TB) is a severe infectious disease affecting the population across the world. Although tuberculosis is a curable disease, it remains one of the most common root causes of death among adults, particularly in developing economies. The government initiatives for promoting detection of TB are increasing globally. With the rise in the incidents of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, tuberculosis testing and diagnostics market is growing.

MARKET SCOPE

The "Global Tuberculosis Testing and Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the tuberculosis testing and diagnostics market with detailed market segmentation by teat type, end use, and geography. The report provides key statistics on the market status of the leading tuberculosis testing and diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on test type, the global tuberculosis testing and diagnostics market is segmented into radiographic method, cytokine detection assay, nucleic acid testing, detection of latent infection, diagnostic laboratory method, detection of drug resistance, others.
  •  On the basis of end use, the market is segmented into clinics, hospitals, research institutes and academics, reference laboratories, others.

MARKET DYNAMICS

Drivers-
  •   Rise in the incidences of tuberculosis globally.
  •   Rise in the geriatric population.
  •   Technological advancements and growth in research activities.
Restraints-
  •   The side effects related like allergies are the major restraining factor for the tuberculosis testing and diagnostics market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The tuberculosis testing and diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the tuberculosis testing and diagnostics market in these regions.

IMPACT OF COVID-19 ON TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the tuberculosis testing and diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from tuberculosis testing and diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for tuberculosis testing and diagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the tuberculosis testing and diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Alere Inc.
  •  F.Hoffmann-La Roche AG
  •  Abbott Laboratories
  •  Becton
  •  Dickinson and Company
  •  bioMérieux SA
  •  Siemens
  •  Hologic Corporation
  •  Cepheid
  •  Hain Lifesciences GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tuberculosis Testing And Diagnostics Market - By Test Type
1.3.2 Tuberculosis Testing And Diagnostics Market - By End Use
1.3.3 Tuberculosis Testing And Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. TUBERCULOSIS TESTING AND DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. TUBERCULOSIS TESTING AND DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TEST TYPE
7.1. OVERVIEW
7.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
7.3. RADIOGRAPHIC METHOD
7.3.1. Overview
7.3.2. Radiographic Method Market Forecast and Analysis
7.4. CYTOKINE DETECTION ASSAY
7.4.1. Overview
7.4.2. Cytokine Detection Assay Market Forecast and Analysis
7.5. NUCLEIC ACID TESTING
7.5.1. Overview
7.5.2. Nucleic Acid Testing Market Forecast and Analysis
7.6. DETECTION OF LATENT INFECTION
7.6.1. Overview
7.6.2. Detection of Latent Infection Market Forecast and Analysis
7.7. DIAGNOSTIC LABORATORY METHOD
7.7.1. Overview
7.7.2. Diagnostic Laboratory Method Market Forecast and Analysis
7.8. DETECTION OF DRUG RESISTANCE
7.8.1. Overview
7.8.2. Detection of Drug Resistance Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. CLINICS
8.3.1. Overview
8.3.2. Clinics Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. RESEARCH INSTITUTES AND ACADEMICS
8.5.1. Overview
8.5.2. Research Institutes and Academics Market Forecast and Analysis
8.6. REFERENCE LABORATORIES
8.6.1. Overview
8.6.2. Reference Laboratories Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Tuberculosis Testing And Diagnostics Market Overview
9.1.2 North America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis
9.1.3 North America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Test Type
9.1.4 North America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By End Use
9.1.5 North America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Tuberculosis Testing And Diagnostics Market
9.1.5.1.1 United States Tuberculosis Testing And Diagnostics Market by Test Type
9.1.5.1.2 United States Tuberculosis Testing And Diagnostics Market by End Use
9.1.5.2 Canada Tuberculosis Testing And Diagnostics Market
9.1.5.2.1 Canada Tuberculosis Testing And Diagnostics Market by Test Type
9.1.5.2.2 Canada Tuberculosis Testing And Diagnostics Market by End Use
9.1.5.3 Mexico Tuberculosis Testing And Diagnostics Market
9.1.5.3.1 Mexico Tuberculosis Testing And Diagnostics Market by Test Type
9.1.5.3.2 Mexico Tuberculosis Testing And Diagnostics Market by End Use
9.2. EUROPE
9.2.1 Europe Tuberculosis Testing And Diagnostics Market Overview
9.2.2 Europe Tuberculosis Testing And Diagnostics Market Forecasts and Analysis
9.2.3 Europe Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Test Type
9.2.4 Europe Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By End Use
9.2.5 Europe Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Tuberculosis Testing And Diagnostics Market
9.2.5.1.1 Germany Tuberculosis Testing And Diagnostics Market by Test Type
9.2.5.1.2 Germany Tuberculosis Testing And Diagnostics Market by End Use
9.2.5.2 France Tuberculosis Testing And Diagnostics Market
9.2.5.2.1 France Tuberculosis Testing And Diagnostics Market by Test Type
9.2.5.2.2 France Tuberculosis Testing And Diagnostics Market by End Use
9.2.5.3 Italy Tuberculosis Testing And Diagnostics Market
9.2.5.3.1 Italy Tuberculosis Testing And Diagnostics Market by Test Type
9.2.5.3.2 Italy Tuberculosis Testing And Diagnostics Market by End Use
9.2.5.4 Spain Tuberculosis Testing And Diagnostics Market
9.2.5.4.1 Spain Tuberculosis Testing And Diagnostics Market by Test Type
9.2.5.4.2 Spain Tuberculosis Testing And Diagnostics Market by End Use
9.2.5.5 United Kingdom Tuberculosis Testing And Diagnostics Market
9.2.5.5.1 United Kingdom Tuberculosis Testing And Diagnostics Market by Test Type
9.2.5.5.2 United Kingdom Tuberculosis Testing And Diagnostics Market by End Use
9.2.5.6 Rest of Europe Tuberculosis Testing And Diagnostics Market
9.2.5.6.1 Rest of Europe Tuberculosis Testing And Diagnostics Market by Test Type
9.2.5.6.2 Rest of Europe Tuberculosis Testing And Diagnostics Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Tuberculosis Testing And Diagnostics Market Overview
9.3.2 Asia-Pacific Tuberculosis Testing And Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Test Type
9.3.4 Asia-Pacific Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Tuberculosis Testing And Diagnostics Market
9.3.5.1.1 Australia Tuberculosis Testing And Diagnostics Market by Test Type
9.3.5.1.2 Australia Tuberculosis Testing And Diagnostics Market by End Use
9.3.5.2 China Tuberculosis Testing And Diagnostics Market
9.3.5.2.1 China Tuberculosis Testing And Diagnostics Market by Test Type
9.3.5.2.2 China Tuberculosis Testing And Diagnostics Market by End Use
9.3.5.3 India Tuberculosis Testing And Diagnostics Market
9.3.5.3.1 India Tuberculosis Testing And Diagnostics Market by Test Type
9.3.5.3.2 India Tuberculosis Testing And Diagnostics Market by End Use
9.3.5.4 Japan Tuberculosis Testing And Diagnostics Market
9.3.5.4.1 Japan Tuberculosis Testing And Diagnostics Market by Test Type
9.3.5.4.2 Japan Tuberculosis Testing And Diagnostics Market by End Use
9.3.5.5 South Korea Tuberculosis Testing And Diagnostics Market
9.3.5.5.1 South Korea Tuberculosis Testing And Diagnostics Market by Test Type
9.3.5.5.2 South Korea Tuberculosis Testing And Diagnostics Market by End Use
9.3.5.6 Rest of Asia-Pacific Tuberculosis Testing And Diagnostics Market
9.3.5.6.1 Rest of Asia-Pacific Tuberculosis Testing And Diagnostics Market by Test Type
9.3.5.6.2 Rest of Asia-Pacific Tuberculosis Testing And Diagnostics Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Tuberculosis Testing And Diagnostics Market Overview
9.4.2 Middle East and Africa Tuberculosis Testing And Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Test Type
9.4.4 Middle East and Africa Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Tuberculosis Testing And Diagnostics Market
9.4.5.1.1 South Africa Tuberculosis Testing And Diagnostics Market by Test Type
9.4.5.1.2 South Africa Tuberculosis Testing And Diagnostics Market by End Use
9.4.5.2 Saudi Arabia Tuberculosis Testing And Diagnostics Market
9.4.5.2.1 Saudi Arabia Tuberculosis Testing And Diagnostics Market by Test Type
9.4.5.2.2 Saudi Arabia Tuberculosis Testing And Diagnostics Market by End Use
9.4.5.3 U.A.E Tuberculosis Testing And Diagnostics Market
9.4.5.3.1 U.A.E Tuberculosis Testing And Diagnostics Market by Test Type
9.4.5.3.2 U.A.E Tuberculosis Testing And Diagnostics Market by End Use
9.4.5.4 Rest of Middle East and Africa Tuberculosis Testing And Diagnostics Market
9.4.5.4.1 Rest of Middle East and Africa Tuberculosis Testing And Diagnostics Market by Test Type
9.4.5.4.2 Rest of Middle East and Africa Tuberculosis Testing And Diagnostics Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Tuberculosis Testing And Diagnostics Market Overview
9.5.2 South and Central America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Test Type
9.5.4 South and Central America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Tuberculosis Testing And Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Tuberculosis Testing And Diagnostics Market
9.5.5.1.1 Brazil Tuberculosis Testing And Diagnostics Market by Test Type
9.5.5.1.2 Brazil Tuberculosis Testing And Diagnostics Market by End Use
9.5.5.2 Argentina Tuberculosis Testing And Diagnostics Market
9.5.5.2.1 Argentina Tuberculosis Testing And Diagnostics Market by Test Type
9.5.5.2.2 Argentina Tuberculosis Testing And Diagnostics Market by End Use
9.5.5.3 Rest of South and Central America Tuberculosis Testing And Diagnostics Market
9.5.5.3.1 Rest of South and Central America Tuberculosis Testing And Diagnostics Market by Test Type
9.5.5.3.2 Rest of South and Central America Tuberculosis Testing And Diagnostics Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. TUBERCULOSIS TESTING AND DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ALERE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F.HOFFMANN-LA ROCHE AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BECTON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DICKINSON AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOMéRIEUX SA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SIEMENS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HOLOGIC CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CEPHEID
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HAIN LIFESCIENCES GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Alere Inc.
2. F.Hoffmann-La Roche AG
3. Abbott Laboratories
4. Becton
5. Dickinson and Company
6. bioMérieux SA
7. Siemens
8. Hologic Corporation
9. Cepheid
10. Hain Lifesciences GmbH
TIPRE00022313
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking